Home LiteratureArticle Details
PMID: 6411853 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

The Journal of experimental medicine ·Vol. 158 ·No. 3 ·1983-09-01 ·Pages 670-89

Nathan CF, Murray HW, Wiebe ME, Rubin BY

Abstract

Human blood mononuclear leukocytes stimulated with toxoplasma antigen, concanavalin A, mezerein plus lentil lectin, or staphylococcal enterotoxin A secreted a factor (macrophage-activating factor, or MAF) that enhanced the capacity of human macrophages to release H2O2 and to kill toxoplasmas. The same lymphoid supernatants contained IFN gamma but not IFN alpha or IFN beta. The MAF activity of six of seven unfractionated supernatants was completely eliminated by a monoclonal antibody that neutralizes IFN gamma, and MAF in the remaining supernatant was almost completely neutralized. Native IFN gamma partially purified by two independent protocols to specific activities of 1 X 10(6) and 10(7) U/mg protein was enriched in MAF activity at least as much as in antiviral activity. The capacity of macrophages to secrete H2O2 after incubation in partially purified native IFN gamma (mean peak stimulation, 8.8-fold) was greater than with unpurified lymphokines (3.8-fold) and sometimes equaled or exceeded the capacity of freshly harvested monocytes. The MAF activity of the partially purified native IFN gamma preparations was abolished by monoclonal anti-IFN gamma. Finally, IFN gamma of greater than 99% estimated purity was isolated (at Genentech, Inc.) from bacteria transformed with the cloned human gene for this lymphokine. Recombinant IFN gamma had potent MAF activity, stimulating the peroxide-releasing capacity of macrophages an average of 19.8-fold at peak response and enhancing their ability to kill toxoplasmas from 2.6 +/- 1.3% for untreated cells to 54 +/- 0.4% for treated cells. Attainment of 50% of the maximal elevation in peroxide-releasing capacity required a geometric mean concentration of 0.1 antiviral U/ml of recombinant IFN gamma, which is estimated to be approximately 6 picomolar for this preparation. Peroxide secretory capacity and toxoplasmacidal activity of macrophages peaked 2-4 d after exposure to IFN gamma. Peroxide-secretory capacity remained elevated during at least 6 d of continuous exposure, but the effect of IFN gamma was reversed within about 3 d of its removal. Activation was usually but not invariably accompanied by characteristic changes in cell morphology. Thus, IFN gamma activates human macrophage oxidative metabolism and antimicrobial activity, and appeared to be the only factor consistently capable of doing so in the diverse LK preparations tested.

MeSH Terms
Adult Antibodies, Monoclonal/physiology Blood Physiological Phenomena Concanavalin A/physiology Humans Hydrogen Peroxide/blood Interferon-gamma/genetics,immunology,physiology Lymphokines/physiology Macrophage Activation Macrophages/metabolism Recombination, Genetic Toxoplasma/growth & development
Chemicals
Antibodies, Monoclonal Lymphokines concanavalin A-induced helper factors Concanavalin A Interferon-gamma Hydrogen Peroxide
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Nathan C F
Murray H W
Wiebe M E
Rubin B Y
References (50)
50 references, click to expand
  1. Mononuclear phagocytes: responders to and producers of interferon.
    Ann N Y Acad Sci. 1980;350:72-90 PMID: 6165307
  2. Inhibition of multiplication of Toxoplasma gondii by human monocytes exposed to T-lymphocyte products.
    J Exp Med. 1975 Feb 1;141(2):483-96 PMID: 1089746
  3. Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity.
    J Exp Med. 1982 Dec 1;156(6):1780-93 PMID: 6816896
  4. Recombinant interferon-gamma increases HLA-DR synthesis and expression.
    J Immunol. 1983 Apr;130(4):1492-4 PMID: 6403609
  5. Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing.
    J Immunol. 1983 May;130(5):2011-3 PMID: 6403616
  6. Induction of an inhibitor of interferon action in a mouse lymphokine preparation.
    Infect Immun. 1979 Dec;26(3):949-55 PMID: 231012
  7. Suppression of intracellular multiplication of Mycobacterium tuberculosis by virus-inhibiting factor or interferon.
    Jpn J Microbiol. 1975 Jun;19(3):235-6 PMID: 809612
  8. Production and properties of Toxoplasma growth inhibitory factor (Toxo-GIF) and interferon (IFN) in the lymphokines and the circulation of Toxoplasma immune mice.
    Zentralbl Bakteriol Mikrobiol Hyg A. 1981 Dec;251(1):134-43 PMID: 6173972
  9. Production and properties of immune interferon from spleen cell cultures of Toxoplasma-infected mice.
    Microbiol Immunol. 1980;24(11):1109-20 PMID: 6163946
  10. Exogenous interferon protects mice against Plasmodium berghei malaria.
    Nature. 1970 Sep 26;227(5265):1350-1 PMID: 5455140
  11. Structure of the human immune interferon gene.
    Nature. 1982 Aug 26;298(5877):859-63 PMID: 6180322
  12. The influence of immunologically committed lymphoid cells on macrophage activity in vivo.
    J Exp Med. 1969 May 1;129(5):973-92 PMID: 4976110
  13. Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells.
    Nucleic Acids Res. 1982 Apr 24;10(8):2487-501 PMID: 6176945
  14. Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin.
    Science. 1965 Jul 16;149(3681):310-1 PMID: 17838106
  15. Hydrogen peroxide metabolism in human monocytes during differentiation in vitro.
    J Clin Invest. 1981 Nov;68(5):1243-52 PMID: 6271809
  16. Enhanced production of murine interferon gamma by T cells generated in response to bacterial infection.
    J Exp Med. 1982 Jul 1;156(1):112-27 PMID: 6177817
  17. Alterations of macrophage functions by mediators from lymphocytes.
    J Exp Med. 1971 Jun 1;133(6):1356-76 PMID: 5576335
  18. The anticellular and protein-inducing activities of human gamma interferon preparations are mediated by the interferon.
    J Immunol. 1983 Mar;130(3):1019-20 PMID: 6401779
  19. Increased secretion of plasminogen activator by human macrophages after exposure to leukocyte interferon.
    FEBS Lett. 1981 Jul 6;129(2):233-6 PMID: 6169547
  20. In vitro induction of nonspecific resistance in macrophages by specifically sensitized lymphocytes.
    Infect Immun. 1971 Oct;4(4):337-43 PMID: 5005299
  21. Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii).
    Science. 1968 Aug 23;161(3843):804-6 PMID: 4298747
  22. Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.
    J Immunol. 1983 Apr;130(4):1784-9 PMID: 6403613
  23. Effect of treatment of mice with sera containing gamma interferon on the course of infection with Salmonella typhimurium strain LT-2.
    J Interferon Res. 1980 Fall;1(1):137-45 PMID: 6180036
  24. Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response.
    J Immunol. 1982 Jan;128(1):123-8 PMID: 6274954
  25. Effect of Interferon and Interferon Inducers on Infections with a Nonviral Intracellular Microorganism, Rickettsia akari.
    Infect Immun. 1971 Jun;3(6):819-24 PMID: 16558061
  26. Reversible inhibition by interferon of the maturation of human peripheral blood monocytes to macrophages.
    Cell Immunol. 1980 Mar 1;50(1):177-90 PMID: 6156767
  27. Expression of human immune interferon cDNA in E. coli and monkey cells.
    Nature. 1982 Feb 11;295(5849):503-8 PMID: 6173769
  28. Characterization of a lymphocyte factor which alters macrophage functions.
    J Exp Med. 1973 Feb 1;137(2):275-90 PMID: 4119587
  29. The enhancement of macrophage bacteriostasis by products of activated lymphocytes.
    J Exp Med. 1973 Oct 1;138(4):952-64 PMID: 4200649
  30. Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products.
    J Immunol. 1976 Aug;117(2):381-7 PMID: 950460
  31. Stimulation of human gamma interferon production by diterpene esters.
    Infect Immun. 1981 Oct;34(1):131-9 PMID: 6170583
  32. Glycosylation of interferons. Effects of tunicamycin on human immune interferon.
    J Biol Chem. 1978 Nov 10;253(21):7612-5 PMID: 701277
  33. Leukocytes and interferon in the host response to viral infections. II. Enhanced interferon response of leukocytes from immune animals.
    J Bacteriol. 1966 Jun;91(6):2185-91 PMID: 5943935
  34. Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates.
    J Exp Med. 1979 Oct 1;150(4):950-64 PMID: 512587
  35. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  36. Studies on the mechanisms of macrophage activation: possible involvement of oxygen metabolites in killing of Leishmania enrietti by activated mouse macrophages.
    J Reticuloendothel Soc. 1981 Mar;29(3):181-92 PMID: 6260943
  37. Migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.
    Infect Immun. 1973 Jan;7(1):68-75 PMID: 16558073
  38. Suppression of the intracellular growth of Shigella flexneri in cell cultures by interferon preparations and polyinosinic-polycytidylic acid.
    Infect Immun. 1972 Mar;5(3):370-6 PMID: 4564562
  39. Trypanosoma cruzi: in vitro induction of macrophage microbicidal activity.
    J Exp Med. 1978 Jul 1;148(1):288-300 PMID: 353218
  40. Interferon activates macrophages to produce plasminogen activator.
    J Interferon Res. 1982;2(3):377-86 PMID: 6890086
  41. A monoclonal antibody that detects a V kappa-TEPC15 idiotypic determinant cross-reactive with a Thy-1 determinant.
    J Exp Med. 1981 May 1;153(5):1068-79 PMID: 6166711
  42. Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes.
    J Clin Invest. 1982 May;69(5):1099-111 PMID: 7068848
  43. IFN-beta-induced reduction of superoxide anion generation by macrophages.
    Immunology. 1982 Apr;45(4):621-8 PMID: 6175565
  44. Immune specific induction of interferon production in cultures of human blood lymphocytes.
    Science. 1969 Jun 20;164(3886):1415-7 PMID: 5783715
  45. Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells.
    J Exp Med. 1982 Oct 1;156(4):945-61 PMID: 7153714
  46. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.
    Proc Natl Acad Sci U S A. 1980 Oct;77(10):5928-32 PMID: 6160587
  47. Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation.
    J Exp Med. 1980 Dec 1;152(6):1596-609 PMID: 6256463
  48. Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity.
    J Clin Invest. 1983 Jul;72(1):32-44 PMID: 6308049
  49. Lymphokines enhance the capacity of human monocytes to secret reactive oxygen intermediates.
    J Clin Invest. 1982 Nov;70(5):1042-8 PMID: 7130393
  50. Activation of macrophages in vivo and in vitro. Correlation between hydrogen peroxide release and killing of Trypanosoma cruzi.
    J Exp Med. 1979 May 1;149(5):1056-68 PMID: 376774
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1983-09-01
Pages
670-89
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2187114
Subset
IM
Grants
NIAID NIH HHS · AI 16963 · United States
NIAID NIH HHS · AI 17920 · United States
NCI NIH HHS · CA-22090 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com